H.F. 249 would allow the board of pharmacy to reclassify Ibogaine, MDMA and Psilocybin controlled substances for medicinal purposes.
H.F. 249 would allow the board of pharmacy to reclassify Ibogaine, MDMA and Psilocybin controlled substances for medicinal purposes.